Analysts Anticipate Sabra Health Care REIT Inc (SBRA) Will Post Quarterly Sales of $150.67 Million

Brokerages expect Sabra Health Care REIT Inc (NASDAQ:SBRA) to report $150.67 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Sabra Health Care REIT’s earnings. The lowest sales estimate is $140.02 million and the highest is $163.41 million. Sabra Health Care REIT reported sales of $166.47 million in the same quarter last year, which suggests a negative year-over-year growth rate of 9.5%. The business is expected to announce its next earnings report on Wednesday, February 20th.

On average, analysts expect that Sabra Health Care REIT will report full year sales of $635.65 million for the current fiscal year, with estimates ranging from $624.22 million to $649.53 million. For the next year, analysts expect that the firm will report sales of $619.97 million, with estimates ranging from $568.86 million to $661.51 million. Zacks Investment Research’s sales averages are an average based on a survey of research firms that follow Sabra Health Care REIT.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings data on Monday, November 5th. The real estate investment trust reported $0.20 EPS for the quarter, missing the consensus estimate of $0.62 by ($0.42). Sabra Health Care REIT had a net margin of 61.85% and a return on equity of 11.80%. The company had revenue of $151.80 million for the quarter, compared to the consensus estimate of $162.64 million.

SBRA has been the subject of several research reports. BidaskClub raised shares of Sabra Health Care REIT from a “hold” rating to a “buy” rating in a report on Saturday, August 18th. Raymond James increased their price objective on shares of Sabra Health Care REIT from $22.00 to $24.00 and gave the company a “buy” rating in a report on Friday, August 17th. Mizuho reissued a “buy” rating and set a $26.00 price objective on shares of Sabra Health Care REIT in a report on Monday, August 13th. Zacks Investment Research raised shares of Sabra Health Care REIT from a “sell” rating to a “hold” rating in a report on Wednesday, October 31st. Finally, ValuEngine raised shares of Sabra Health Care REIT from a “sell” rating to a “hold” rating in a report on Tuesday, October 9th. Four equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. Sabra Health Care REIT currently has a consensus rating of “Hold” and an average target price of $22.00.

Large investors have recently made changes to their positions in the stock. Qube Research & Technologies Ltd bought a new position in shares of Sabra Health Care REIT in the 2nd quarter valued at about $115,000. US Bancorp DE lifted its holdings in shares of Sabra Health Care REIT by 91.5% in the 2nd quarter. US Bancorp DE now owns 5,699 shares of the real estate investment trust’s stock valued at $124,000 after acquiring an additional 2,723 shares during the last quarter. Centaurus Financial Inc. bought a new position in shares of Sabra Health Care REIT in the 2nd quarter valued at about $125,000. NEXT Financial Group Inc bought a new position in shares of Sabra Health Care REIT in the 3rd quarter valued at about $132,000. Finally, Winslow Evans & Crocker Inc. bought a new position in shares of Sabra Health Care REIT in the 3rd quarter valued at about $162,000. 92.24% of the stock is owned by hedge funds and other institutional investors.

Shares of SBRA traded up $0.01 during midday trading on Wednesday, hitting $19.30. 1,689,619 shares of the company traded hands, compared to its average volume of 1,685,527. Sabra Health Care REIT has a 52 week low of $15.77 and a 52 week high of $23.83. The company has a market capitalization of $3.44 billion, a PE ratio of 7.94, a price-to-earnings-growth ratio of 2.41 and a beta of 0.54. The company has a quick ratio of 2.88, a current ratio of 2.88 and a debt-to-equity ratio of 1.00.

The firm also recently declared a quarterly dividend, which was paid on Friday, November 30th. Investors of record on Thursday, November 15th were issued a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a dividend yield of 9.33%. The ex-dividend date of this dividend was Wednesday, November 14th. Sabra Health Care REIT’s payout ratio is 74.07%.

Sabra Health Care REIT Company Profile

As of September 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 350 Skilled Nursing/Transitional Care facilities, (ii) 91 Senior Housing communities (“Senior Housing – Leased”), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing – Managed”) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 11 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Featured Article: Market Capitalization

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit